Matthew Piscitelli provides comprehensive advice to FDA-regulated clients on topics including clinical trials, manufacturing compliance, product exclusivity, and advertising and promotion. He has advised drug, biologic, and device companies through complex, multi-national transactions and both internal and government investigations. Matthew regularly advises clients on the scope, applicability, and interactivity of exclusivities granted by FDA and USPTO.